https://marijuanaindex.com/sector/biotechnology/ Check out

New Post Public Reply Private Reply Replies (1) Message Board
kickazzstocktrader mick #47
5,107
https://marijuanaindex.com/sector/biotechnology/ Check out who is listed as #31 on this list!!!!!!!

32 Companies
Name Symbol Price Change % Volume Market Cap Exchange
GW Pharmaceuticals Plc GWPH 117.930 1.39 % 281,219 $2.97b NSD
Insys Therapeutics Inc. INSY 11.030 6.47 % 1,050,617 $793.69m NSD
Axim Biotechnologies Inc AXIM 13.350 11.16 % 63,248 $687.43m OTCQB
Zynerba Pharmaceuticals Inc. ZYNE 24.780 12.18 % 1,709,777 $327.46m NSD
Cannabics Pharmaceuticals Inc CNBX 2.570 -6.20 % 1,082,513 $293.29m OTCQB
Cure Pharmaceutical Holding Corp CURR 6.800 -4.90 % 3,655 $169.89m OTCQB
Cannabis Science Inc CBIS 0.071 -5.07 % 33,704,736 $164.64m OTCPK
22nd Century Group Inc. XXII 1.330 -1.48 % 838,617 $122.44m NYSE MKT
OWC Pharmaceutical Research Corp OWCP 0.720 -18.18 % 5,536,826 $97.42m OTCQB
InMed Pharmaceuticals Inc IN:CNX 0.880 15.79 % 2,474,652 $95.34m CSE
PharmaCyte Biotech Inc PMCB 0.097 2.55 % 1,241,658 $84.47m OTCQB
InMed Pharmaceuticals Inc IMLFF 0.657 13.42 % 2,678,367 $71.15m OTCQB
Tetra Bio Pharma Inc TBP:CNX 0.690 1.47 % 729,880 $68.54m CSE
Tetra Bio-Pharma Inc GRPOF 0.513 0.51 % 125,154 $50.92m OTCQB
Kalytera Therapeutics Inc KALY:CA 0.400 1.27 % 864,373 $50.29m TSXVAbattis Bioceuticals Corp ATT:CNX 0.340 19.30 % 6,129,756 $45.46m CSE
GB Sciences Inc GBLX 0.325 3.83 % 743,282 $36.04m OTCQB
Vitality Biopharma VBIO 2.000 2.77 % 121,450 $35.57m OTCQB
Abattis Bioceuticals Ord ATTBF 0.250 19.05 % 4,859,493 $33.42m OTCQB
Omni Health Inc OMHE 0.022 -4.31 % 67,436 $21.66m OTCPK
Easton Pharms Inc EAPH 0.031 15.93 % 5,357,644 $18.16m OTCPK
India Globalization Capital Inc. IGC 0.540 7.12 % 426,334 $13.92m NYSE MKT
Veritas Pharma Inc VRT:CNX 0.520 4.00 % 205,060 $12.91m CSE
CannaPharmaRx Inc CPMD 0.600 0.00 % 50 $10.78m OTCPK
Veritas Pharma Inc VRTHF 0.389 4.91 % 26,700 $9.65m OTCPK
Nemus Bioscience Inc. NMUS 0.315 5.00 % 181,762 $8.10m OTCQB
Therapix Biosciences Ltd. TRPX 7.850 5.51 % 93,740 $6.95m NCM
Generex Biotechnology GNBT 4.500 -4.26 % 1,710 $6.12m OTCPK
Premier Biomedical Inc BIEI 0.017 2.99 % 1,798,000 $3.90m OTCQB
Plandai Biotechnology Inc PLPL 0.015 -14.29 % 996,153 $2.80m OTCPK
ViaDerma Inc VDRM 0.025 1.64 % 6,224,086 $1.86m OTCPK
Verde Science Inc VRCI 0.009 -14.14 % 168,732 $202.88k OTCPK


http://business.financialpost.com/news/agricu...-provinces

Legalization will be announced this Thursday, April 13, 2017 in Canada!

Lets have look at the PR again...
The Cannabis Provisional Patent #62466209, a patent for delivering medical marijuana /cannabis to the body by applying the medication onto the skin in an ointment base topical solution. The second provisional patent #62433964 for enhanced antibiotic and drug delivery for "Aqueous Topical Applications" for human and veterinarian uses. The Company plans to continue to expand its (IP) "Intellectual Property Portfolio" in 2017.

The Company has signed a LOI or letter of intent to work with a Canadian-based investment group with expertise in logistics that includes distribution for the new and anticipated products. The investment group will target sales for the new patent pending products to countries that have accepted "Medical Marijuana" and "Recreational Use" of cannabis products and technologies for delivery of CBD and THC. This group will also target countries that allow the "Clinical Studies" for medical testing such as the United Kingdom and other Asian countries.

http://www.marketwired.com/press-release/viad...203945.htm


This alone will send us over 50 cents, let alone the FDA approval coming in 6 weeks, updates from the DFCon, 500,000 units at $125/ in sales coming this year, among all the other things in the pipeline!

We will be trading $$'s soon! This will be one of the stocks of the year!!
BUY WHAT YOU CAN here!! We're talking 1000%+ returns at these levels.
Lets consider a $25,000 investment @ .025, gives you 1,000,000 shares.
When we hit $2.50, that investment will be worth $2,500,000
Millionaires will be made here

I am 99.9% confident we will hit $$'s by summer.

ViaDerma, Inc. (VDRM) Stock Research Links

VDRM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 1

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 7

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 7

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 5

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 5

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading

Top 5 Most Recently Viewed Articles

New Oriental Reports Major Financial Growth for Latest Quarter

Updated Category News Views 103

New Oriental Education & Technology Group Inc. Financial Results Overview New Oriental Education & Technology Group Inc. (NYSE: EDU) has recently unveiled its unaudited financial results for the second fiscal quarter ended November 30. This marks a significant period in the company's journey, highlighting an impressive rise in net revenues and overall financial...

Continue Reading
Continued Confidence Among CEOs and Investors in 2026 Growth

Updated Category News Views 137

Continued Confidence Among CEOs and Investors in 2026 Growth Recent insights reveal that CEO and investor expectations for growth, mergers and acquisitions (M&A), and hiring are notably high. However, these aspirations come with caution, spurred by challenges related to global trade, geopolitical uncertainties, and rapid technological advancements. High Expectations for...

Continue Reading
Understanding S&P 500 E-Mini Trends: Are We in for a Shift?

Updated Category News Views 201

The S&P 500 E-Mini futures market saw quite the ruckus back then. As traders scanned the weekly charts, smaller candlestick patterns hinted at a shift in momentum that got everyone on edge. They had their eyes glued to that 20-week exponential moving average (EMA)—a critical support level that bulls hoped would come through for them as they scrambled for a double-bottom...

Continue Reading
Understanding Recent Legal Challenges Facing Nutex Health Inc.

Updated Category News Views 127

The Current Legal Landscape for Nutex Health Inc. Nutex Health Inc. is currently facing significant legal challenges that have sparked interest among its investors and market watchers. These challenges are crucial to understanding the company’s financial health and future prospects. Recently, a class action lawsuit was announced against the Company, raising concerns...

Continue Reading
BellRing Brands Faces Legal Scrutiny: Investors Encouraged to Engage

Updated Category News Views 120

Introduction to the Investigation Bragar Eagel & Squire, P.C., a respected law firm focused on investor rights, is currently investigating potential claims against BellRing Brands Inc. (BRBR). This inquiry aims to determine whether the company violated federal securities laws or engaged in unlawful business practices, impacting their shareholders. Investors who have...

Continue Reading